Products
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 20300 | Acoramidis (AG-10 ) | 1446711-81-4 | ≧98.0% |  |
| Acoramidis (formerly AG10) is an investigational, orally-administered small molecule | ||||
| 11022 | WP-1130 | 856243-80-6 | 98% Min. |  |
| Degrasyn, also known as WP1130, is a small molecule that specifically and rapidly dow | ||||
| 20302 | VAS3947 | 869853-70-3 | ≧98.0% |  |
| VAS3947 is a selective inhibitor of NADPH oxidase activity in low micromolar concentr | ||||
| 20305 | ONC201 HCl | 1638178-82-1 | 98% Min. |  |
| ONC-201, also known as TIC10 and imipridone, is a potent, orally active, and stable s | ||||
| 20306 | SRI-37330 HCl | 2322245-49-6 | ≧98.0% |  |
| SRI-37330 hydrochloride is a novel inhibitor of TXNIP expression,and dose-dependently | ||||
| 20308 | 4-(chloromethyl)-1-cyclopentyl-2-(trifluoromethyl)benzene | 957208-65-0 | ≧98.0% | -1-cyclopentyl-2-(trifluoromethyl)benzene_957208-65-0.png) |
| 20310 | 4-chloro-6-(trifluoromethyl)quinazoline | 16499-64-2 | 98% Min. | quinazoline_16499-64-2.png) |
| 20311 | 6-(TRIFLUOROMETHYL)QUINAZOLIN-4(3H)-ONE | 16544-67-5 | 98% Min. | QUINAZOLIN-4(3H)-ONE_16544-67-5.png) |
| 20312 | 2-AMINO-5-TRIFLUOROMETHYL-BENZOIC ACID | 83265-53-6 | 98% Min. |  |
| 20314 | Obicetrapib | 866399-87-3 | 98% Min. |  |
| Obicetrapib (also known as AMG-899, TA-8995, and DEX-001) is a cholesteryl ester tran | ||||
| 20318 | Zotizalkib ( TPX-0131 ) | 2648641-36-3 | ≧98.0% | _2648641-36-3.png) |
| TPX-0131 is a next-generation ALK inhibitor drug candidate currently being evaluated | ||||
| 20344 | SMN-C3 | 1449597-34-5 | ≧98.0% |  |
| SMN-C3is an orally active SMN2 splicing modulator and has the potential to treat spin | ||||